open access

Vol 10, Supp. F (2014)
suplement
Published online: 2014-12-12
Get Citation

Long-term treatment with fulvestrant in breast cancer patient with metastases in liver and bones

Łukasz Kwinta, Wojciech Melerowicz

open access

Vol 10, Supp. F (2014)
suplement
Published online: 2014-12-12

Abstract

Breast cancer is the most common female malignancy, and therefore it is a very important problem in daily oncological practice. Systemic treatment of breast cancer involves hormonal therapy, chemotherapy and therapy targeted against receptors for epidermal growth factor. Hormonal therapy plays crucial role in treatment of hormone receptor-positive metastatic breast cancer. It often allows to achieve long-term response with low toxicity of treatment. In this case report we present description of course of treatment in patient in whom fulvestrant allowed to obtain long-term objective clinical response.

Abstract

Breast cancer is the most common female malignancy, and therefore it is a very important problem in daily oncological practice. Systemic treatment of breast cancer involves hormonal therapy, chemotherapy and therapy targeted against receptors for epidermal growth factor. Hormonal therapy plays crucial role in treatment of hormone receptor-positive metastatic breast cancer. It often allows to achieve long-term response with low toxicity of treatment. In this case report we present description of course of treatment in patient in whom fulvestrant allowed to obtain long-term objective clinical response.

Get Citation

Keywords

breast cancer, hormonal therapy, fulvestrant

About this article
Title

Long-term treatment with fulvestrant in breast cancer patient with metastases in liver and bones

Journal

Oncology in Clinical Practice

Issue

Vol 10, Supp. F (2014)

Pages

13-15

Published online

2014-12-12

Keywords

breast cancer
hormonal therapy
fulvestrant

Authors

Łukasz Kwinta
Wojciech Melerowicz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl